Addex Therapeutics (ADXN) Stock: Buy, Sell, or Hold?
ADXN - Addex Therapeutics Ltd American Depositary Shares
$2.97
0.08 (2.69%)
â˛
5d:
+7.61%
30d:
-14.16%
90d:
-48.08%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Dec 03, 2026
Get Alerted When ADXN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: ADXN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: ADXN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: ADXN is currently trading at $2.97, which is considered slightly low relative to its 30-day fair value range of $2.85 to $3.37.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $2.64, while resistance sits at $3.25.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+910.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ADXN is in a strong downtrend. Immediate support is located at $2.64, while resistance sits at $3.25.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+910.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.85 -
$3.37
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 910.1% below Wall St target ($30.00)
- WARNING: Composite score 41/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.85 -
$3.37
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.64
Resistance Level
$3.25
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Wall Street Target
$30.00
(+910.1%)
Revenue Growth (YoY)
-72.7%
Share & Embed Analysis
Last updated: October 26, 2026 2:19 AM ET
Data refreshes hourly during market hours. Next update: 3:19 AM
Data refreshes hourly during market hours. Next update: 3:19 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ADXN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$294 | 64 BUY |
|
PRAX
Praxis Precision MedicinâĻ |
STRONG BUY
21 analysts |
$650 | 65 BUY |
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$867 | 35 SELL |
|
ELVN
Enliven Therapeutics Inc. |
STRONG BUY
14 analysts |
$74 | 65 BUY |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
STRONG BUY
20 analysts |
$31 | 61 BUY |
